This inventor holds 1 USPTO granted patent. Top assignee: Institut Pasteur. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Carlos Massayuki Kikuti
Introduction
Carlos Massayuki Kikuti is a notable inventor based in Bagneux, France. He has made significant contributions to the field of biotechnology, particularly in relation to Hepatitis C virus (HCV) research. His work focuses on developing innovative solutions for the prevention, treatment, and diagnosis of HCV infections.
Latest Patents
Kikuti holds a patent for HCV-derived polypeptides and nucleic acid molecules encoding the same. This invention specifically includes a cd81-binding region, which enhances the effectiveness of the polypeptides or nucleic acid molecules in various medical applications. The patent is crucial for advancing therapeutic strategies against HCV infections.
Career Highlights
Carlos Kikuti is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work at this renowned institution has allowed him to collaborate with leading scientists in the field. Kikuti's innovative approach and dedication to his research have positioned him as a key figure in the fight against Hepatitis C.
Collaborations
Some of his notable coworkers include Thomas Krey and Felix Augusto Rey. Their collaborative efforts contribute to the advancement of research in HCV and related fields.
Conclusion
Carlos Massayuki Kikuti's contributions to biotechnology and his innovative patent for HCV-derived polypeptides highlight his importance in the scientific community. His work continues to pave the way for new treatments and diagnostic methods for Hepatitis C infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile